# OnCo record cartbcma-hcb-01 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/cartbcma-hcb-01/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "cartbcma-hcb-01", "NCT04309981" ;
  schema:name "CARTBCMA-HCB-01 (ARI0002h BCMA CAR-T, Hospital Clínic de Barcelona)"@en ;
  schema:alternateName "CARTBCMA-HCB-01"@en, "ARI0002h pilot study"@en, "cesnicabtagene autoleucel"@en ;
  schema:description "Hospital Clínic's second home-made CAR-T, aimed at BCMA in myeloma, given in fractions with a booster dose; every treated patient responded at the interim analysis, and Spain's health service now pays for it."@en ;
  schema:url <https://onco.cc/trials/cartbcma-hcb-01/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04309981>, <https://doi.org/10.1016/S1470-2045(23)00222-X>, <https://pubmed.ncbi.nlm.nih.gov/37414060/>, <https://www.sanidad.gob.es/areas/farmacia/infoMedicamentos/terapiasAvanzadas/home.htm> ;
  onco:status "positive" ;
  onco:phase "1/2" ;
  schema:startDate "2020-05-27" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/point-of-care-cell-manufacturing/> ;
  onco:targets <https://onco.cc/targets/bcma/> ;
  onco:institutions <https://onco.cc/institutions/hospital-clinic-barcelona/>, <https://onco.cc/institutions/isciii/> ;
  onco:terms <https://onco.cc/terms/crs/> ;
  onco:people <https://onco.cc/people/julio-delgado/>, <https://onco.cc/people/manel-juan/>, <https://onco.cc/people/maria-victoria-mateos/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-cartbcma-hcb-01-lancet-oncol-2023/> .
